No front page content has been created yet.
Specialize in investing in biotech start-ups which develop novel therapeutics targeting critical diseases, and high-end medical device start-ups aiming for import-substitution.
Specialize in investing in the enterprise-class service platforms and data intelligence equipment companies that are engaged in digitalization/intelligence on the supply side of consumption.
（figures as of Oct. 2021）
© 2021 Panlin Capital. All Rights Reserved.